DONG WON HWANG
Papers
1
Total Citations
5
H-Index
1
About
Dr. Dong Won Hwang is a reproductive surgeon and clinical researcher whose work focuses on optimizing surgical outcomes for women with uterine fibroids, particularly through minimally invasive techniques. His major contributions center on improving the safety and efficacy of robot-assisted laparoscopic myomectomy, with a specific emphasis on intraoperative bleeding control. In his landmark randomized controlled pilot trial, the VALENTINE Trial (2023), Dr. Hwang investigated the effect and safety of diluted vasopressin injection during robotic myomectomy in reproductive-age women. This study addressed a critical clinical concern: while vasopressin effectively reduces blood loss, it can cause dangerous vasoconstriction and hypertension due to systemic absorption. By demonstrating the viability of a diluted formulation, his work provides evidence-based guidance for safer surgical practice, helping to preserve fertility while minimizing complications. Though early in its citation history, this trial has already garnered 5 citations, signaling its growing influence in reproductive surgery. Dr. Hwang’s research bridges the gap between surgical innovation and patient safety, offering practical solutions that directly impact clinical protocols for women seeking uterine-sparing treatments.
Research Focus
Key Achievements
Top Papers
- 1